Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?

Leukemia and Lymphoma

Volumn 49, Issue 10, 2008, Pages 1852-1853

  Ritchie, David ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CONTROL; CANCER STEM CELL; CELLULAR IMMUNITY; DISEASE COURSE; FOLLICULAR LYMPHOMA; HUMAN; LYMPHOCYTIC INFILTRATION; NOTE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; T LYMPHOCYTE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; NEOPLASTIC STEM CELLS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 55049132273     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802491714     Document Type: Note

References (9)

1. Fitzgibbon, J., Iqbal, S. Davies, A. et al. (2007) Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia, 21, pp. 1514-1520.
2. Davies, A. J., Rosenwald, A. Wright, G. et al. (2007) Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol, 136, pp. 286-293.
3. Dave, S. S., Wright, G. Tan, B. et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med, 351, pp. 2159-2169.
4. Smyth, M. J., Dunn, G. P. and Schreiber, R. D. (2006) Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol, 90, pp. 1-50.
5. Hamadani, M., Farrukh, A., Elder, P. Lin, T. et al. (2008) Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. Leuk Lymphoma, 49, pp. 1893-1898.
6. Novitzky, N. and Thomas, V. (2007) Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies. Biol Blood Marrow Transplant, 13, pp. 107-115.
7. Rezvani, A. R., Storer, B., Maris, M., Sorror, M. L., Agura, E. Maziarz, R. T. et al. (2008) Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. J Clin Oncol, 26, pp. 211-217.
8. Hertzberg, M., Grigg, A., Gottlieb, D., Szer, J., Roberts, A. Hoyt, R. et al. (2006) Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders. Bone Marrow Transplant, 37, pp. 923-928.
9. Grigg, A. and Ritchie, D. (2004) Graft-versus-lymphoma effects: Clinical review, policy proposals, and immunobiology. Biol Blood Marrow Transplant, 10, pp. 579-590.